Stock Rating Report for ABAX

Ticker: 

Stock Information

Ticker ABAX
Company Name Abaxis Inc
Current Price $28.86
Previous Close $28.86
Industry Diagnostic Substances
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ABAX. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Abaxis Inc next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in veterinary or human patient-care setting to provide blood constituent measurements for clinicians worldwide. The company offers point-of-care blood chemistry analyzer to perform 14 tests on human patients and 13 tests on veterinary patients. It markets the blood analysis system under the Piccolo Xpress and Piccolo Classic names in the medical market- and under the VetScan VS2 and VetScan Classic names in the veterinary market. The company also provides reagent discs to handle various technical steps of blood chemistry testing- and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments for veterinary applications. In addition, its products include VetScan VSpro, which assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, evaluation of disseminated intravascular coagulation, hepatic disease, monitoring therapy, and the progression of disease states. Further, the company offers VetScan VSpro fibrinogen test to provide in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample- and VetScan i-STAT 1 that delivers blood gas, electrolyte, basic blood chemistry, and hematology results. Additionally, its products comprise VetScan Canine heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma- VetScan Canine parvovirus rapid test kit to detect canine parvovirus antigen in feces- VetScan Giardia rapid test to detect giardiasis, a gastrointestinal infection caused by the protozoan parasite Giardia- and Orbos Discrete Lyophilization process that involves in flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. Abaxis sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.


Latest News

Wed, 08 Feb 2012 05:01:24 GMTReady to bet on small company growth stocks?
Sat, 28 Jan 2012 14:21:04 GMTNew Star Analyst Rankings for ABAXIS, Inc.
Fri, 27 Jan 2012 21:55:22 GMTAlere's Flu Test Gains FDA Waiver
Fri, 27 Jan 2012 19:57:47 GMTAbaxis Shares Plunged: What You Need to Know
Fri, 27 Jan 2012 18:17:51 GMTNasdaq stocks posting largest percentage decreases
Fri, 27 Jan 2012 17:31:03 GMTAbaxis Misses on the Top and Bottom Lines
Fri, 27 Jan 2012 15:45:23 GMTDisappointing 3Q for Abaxis
Fri, 27 Jan 2012 14:40:38 GMTGappers report: Bearish gaps
Fri, 27 Jan 2012 14:40:38 GMTGappers report: Bearish gaps
Thu, 26 Jan 2012 21:01:27 GMTABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Thu, 26 Jan 2012 21:00:00 GMTAbaxis Reports Financial Performance for the Third Quarter of Fiscal 2012
Thu, 26 Jan 2012 12:45:00 GMTAbaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Thu, 26 Jan 2012 12:07:28 GMTQ3 2012 ABAXIS INC Earnings Release - After Market Close
Fri, 20 Jan 2012 13:20:36 GMT[video] Spending On Pets Still Strong, Says Heska CEO
Tue, 17 Jan 2012 12:00:00 GMTAbaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Fri, 06 Jan 2012 13:53:24 GMTCoverage initiated on Abaxis by Feltl & Co. and Canaccord Genuity
Fri, 06 Jan 2012 12:15:16 GMTAbaxis initiated with a Hold at Canaccord
Wed, 28 Dec 2011 20:30:20 GMTAbaxis Develops New Veterinary Test
Tue, 27 Dec 2011 13:00:00 GMTAbaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Fri, 23 Dec 2011 15:30:19 GMTAbaxis Expands Rapid Test Portfolio
News provided by Yahoo! Finance